Trials / Completed
CompletedNCT00363324
Bone Marrow Cells in Myocardial Infarction
Effects of Autologous Bone Marrow Celss on Acute ST-Elevation Myocardial Infarction
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of Oulu · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to assess the effect of bone marrow cells on arrhythmia risk variables in patients with a acute myocardial infarction.
Detailed description
This is a randomized, double-blinded study, where patients treated with thrombolytic therapy for acute myocardial infarction are randomized to receive bone-marrow derived stem cells or sham-infusion at the time percutaneous coronary intervention of the target vessel. The end-points are many arrhythmia risk variables, suchs as heart rate variability, T-wave alternans and many ECG variables as well as systolic and diastolic left ventricular function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | intracoronary injection of bone marrow cells |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2006-08-15
- Last updated
- 2008-01-09
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00363324. Inclusion in this directory is not an endorsement.